Home > National Drug Code (NDC) > Bitter Dock

Bitter Dock - 49288-0630-1 - (Bitter Dock)

Alphabetical Index


Drug Information of Bitter Dock

Product NDC: 49288-0630
Proprietary Name: Bitter Dock
Non Proprietary Name: Bitter Dock
Active Ingredient(s): .05    g/mL & nbsp;   Bitter Dock
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Bitter Dock

Product NDC: 49288-0630
Labeler Name: Antigen Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA102223
Marketing Category: BLA
Start Marketing Date: 19740323

Package Information of Bitter Dock

Package NDC: 49288-0630-1
Package Description: 2 mL in 1 VIAL, MULTI-DOSE (49288-0630-1)

NDC Information of Bitter Dock

NDC Code 49288-0630-1
Proprietary Name Bitter Dock
Package Description 2 mL in 1 VIAL, MULTI-DOSE (49288-0630-1)
Product NDC 49288-0630
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Bitter Dock
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 19740323
Marketing Category Name BLA
Labeler Name Antigen Laboratories, Inc.
Substance Name RUMEX OBTUSIFOLIUS POLLEN
Strength Number .05
Strength Unit g/mL
Pharmaceutical Classes Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Bitter Dock


General Information